Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 57 | 2024 | 5753 | 3.600 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 11 | 2023 | 272 | 3.550 |
Why?
|
Graft vs Host Disease | 41 | 2024 | 3078 | 3.340 |
Why?
|
Immunotherapy, Adoptive | 19 | 2024 | 1510 | 1.970 |
Why?
|
Transplantation, Homologous | 23 | 2024 | 4860 | 1.450 |
Why?
|
Transplantation Conditioning | 18 | 2024 | 1635 | 1.300 |
Why?
|
Hematologic Neoplasms | 16 | 2024 | 1927 | 1.100 |
Why?
|
Cord Blood Stem Cell Transplantation | 4 | 2019 | 316 | 1.080 |
Why?
|
Epstein-Barr Virus Infections | 6 | 2024 | 617 | 1.040 |
Why?
|
Lymphoproliferative Disorders | 3 | 2024 | 526 | 1.000 |
Why?
|
Herpesvirus 4, Human | 9 | 2024 | 1078 | 0.900 |
Why?
|
Myelodysplastic Syndromes | 6 | 2024 | 1404 | 0.840 |
Why?
|
Antigens, CD34 | 3 | 2024 | 656 | 0.830 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 2 | 2018 | 95 | 0.740 |
Why?
|
T-Lymphocytes | 15 | 2024 | 10261 | 0.710 |
Why?
|
Leukemia, Myeloid, Acute | 10 | 2024 | 3646 | 0.700 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2022 | 305 | 0.650 |
Why?
|
Treatment Failure | 3 | 2024 | 2652 | 0.650 |
Why?
|
Interleukin-2 | 8 | 2022 | 1896 | 0.640 |
Why?
|
Myeloablative Agonists | 4 | 2018 | 215 | 0.630 |
Why?
|
Macrophage Activation Syndrome | 1 | 2019 | 124 | 0.610 |
Why?
|
Graft vs Tumor Effect | 1 | 2016 | 70 | 0.520 |
Why?
|
Transplants | 1 | 2018 | 208 | 0.520 |
Why?
|
Graft vs Leukemia Effect | 2 | 2020 | 122 | 0.500 |
Why?
|
Fetal Blood | 3 | 2016 | 1369 | 0.490 |
Why?
|
Blood Specimen Collection | 1 | 2016 | 238 | 0.490 |
Why?
|
Lymphocyte Transfusion | 1 | 2016 | 236 | 0.480 |
Why?
|
Neurotoxicity Syndromes | 4 | 2023 | 302 | 0.480 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2018 | 548 | 0.470 |
Why?
|
Receptors, Antigen, T-Cell | 8 | 2024 | 2570 | 0.440 |
Why?
|
Hepatic Veno-Occlusive Disease | 3 | 2022 | 221 | 0.440 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2022 | 3111 | 0.440 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 689 | 0.430 |
Why?
|
Antilymphocyte Serum | 1 | 2015 | 493 | 0.420 |
Why?
|
Hematopoietic Stem Cells | 5 | 2022 | 3401 | 0.410 |
Why?
|
Viral Matrix Proteins | 1 | 2014 | 192 | 0.410 |
Why?
|
Lymphoma | 4 | 2020 | 1897 | 0.400 |
Why?
|
Cytokines | 6 | 2024 | 7421 | 0.390 |
Why?
|
Recurrence | 16 | 2024 | 8501 | 0.380 |
Why?
|
Antigens, CD19 | 4 | 2022 | 443 | 0.360 |
Why?
|
Tissue Donors | 5 | 2022 | 2395 | 0.350 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1203 | 0.330 |
Why?
|
Humans | 118 | 2024 | 765968 | 0.330 |
Why?
|
Organ Transplantation | 3 | 2024 | 1174 | 0.330 |
Why?
|
Blood Component Removal | 2 | 2022 | 124 | 0.330 |
Why?
|
Pyrazoles | 2 | 2019 | 2033 | 0.320 |
Why?
|
Adult | 61 | 2024 | 223044 | 0.320 |
Why?
|
Virus Diseases | 1 | 2015 | 718 | 0.320 |
Why?
|
Antiphospholipid Syndrome | 1 | 2010 | 166 | 0.300 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 3 | 2003 | 158 | 0.290 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2020 | 1376 | 0.290 |
Why?
|
Ferritins | 3 | 2022 | 600 | 0.290 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2022 | 1434 | 0.280 |
Why?
|
B-Lymphocytes | 5 | 2024 | 4778 | 0.270 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2020 | 4405 | 0.270 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2014 | 1801 | 0.270 |
Why?
|
Steroids | 6 | 2023 | 933 | 0.260 |
Why?
|
Aged | 42 | 2024 | 171117 | 0.250 |
Why?
|
Middle Aged | 48 | 2024 | 223009 | 0.240 |
Why?
|
Multiple Myeloma | 2 | 2023 | 5197 | 0.240 |
Why?
|
Cyclophosphamide | 6 | 2023 | 2228 | 0.230 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 1646 | 0.230 |
Why?
|
Killer Cells, Natural | 6 | 2022 | 2210 | 0.230 |
Why?
|
CD8-Positive T-Lymphocytes | 9 | 2024 | 4642 | 0.230 |
Why?
|
Dioxygenases | 3 | 2021 | 354 | 0.230 |
Why?
|
Transplantation Chimera | 3 | 2015 | 609 | 0.220 |
Why?
|
Hematopoietic Stem Cell Mobilization | 3 | 2022 | 227 | 0.220 |
Why?
|
Male | 50 | 2024 | 363698 | 0.210 |
Why?
|
Young Adult | 20 | 2024 | 59889 | 0.210 |
Why?
|
Activated-Leukocyte Cell Adhesion Molecule | 1 | 2022 | 21 | 0.210 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2003 | 1347 | 0.200 |
Why?
|
Perforin | 2 | 2018 | 166 | 0.200 |
Why?
|
Female | 50 | 2024 | 396112 | 0.190 |
Why?
|
Transplantation, Autologous | 4 | 2021 | 2120 | 0.190 |
Why?
|
Ligands | 2 | 2018 | 3273 | 0.190 |
Why?
|
Autoantibodies | 1 | 2010 | 2113 | 0.180 |
Why?
|
Anemia, Sickle Cell | 2 | 2020 | 1067 | 0.180 |
Why?
|
Opportunistic Infections | 1 | 2023 | 376 | 0.180 |
Why?
|
Clone Cells | 4 | 2020 | 1672 | 0.180 |
Why?
|
Natural Killer T-Cells | 1 | 2024 | 319 | 0.180 |
Why?
|
Survival Rate | 9 | 2022 | 12795 | 0.170 |
Why?
|
gamma-Globins | 1 | 2020 | 105 | 0.170 |
Why?
|
Janus Kinase 1 | 1 | 2019 | 108 | 0.160 |
Why?
|
Certification | 1 | 2023 | 416 | 0.160 |
Why?
|
BK Virus | 1 | 2020 | 121 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 226 | 0.160 |
Why?
|
Photopheresis | 1 | 2019 | 35 | 0.160 |
Why?
|
Disease-Free Survival | 6 | 2018 | 6832 | 0.150 |
Why?
|
Retrospective Studies | 21 | 2024 | 81514 | 0.150 |
Why?
|
Bone Marrow Transplantation | 2 | 2023 | 2729 | 0.150 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2019 | 297 | 0.150 |
Why?
|
Biological Products | 3 | 2022 | 942 | 0.150 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2018 | 266 | 0.150 |
Why?
|
Lymphocyte Activation | 4 | 2022 | 5501 | 0.150 |
Why?
|
Fetal Hemoglobin | 1 | 2020 | 348 | 0.150 |
Why?
|
Chronic Disease | 11 | 2023 | 9347 | 0.140 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2021 | 657 | 0.140 |
Why?
|
Vidarabine | 4 | 2021 | 343 | 0.140 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 245 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 836 | 0.140 |
Why?
|
Sulfonamides | 2 | 2024 | 1984 | 0.140 |
Why?
|
Treatment Outcome | 12 | 2024 | 65188 | 0.130 |
Why?
|
Hematologic Diseases | 2 | 2018 | 500 | 0.130 |
Why?
|
Clinical Trials as Topic | 4 | 2021 | 8041 | 0.130 |
Why?
|
Janus Kinase 2 | 1 | 2019 | 562 | 0.130 |
Why?
|
Cryopreservation | 2 | 2021 | 728 | 0.130 |
Why?
|
Tacrolimus | 4 | 2023 | 753 | 0.130 |
Why?
|
Down-Regulation | 2 | 2020 | 2927 | 0.120 |
Why?
|
Tandem Repeat Sequences | 1 | 2016 | 184 | 0.120 |
Why?
|
Stem Cell Factor | 1 | 2015 | 194 | 0.120 |
Why?
|
Interleukin-7 | 1 | 2015 | 147 | 0.120 |
Why?
|
Kidney | 2 | 2010 | 7066 | 0.120 |
Why?
|
Mediastinal Neoplasms | 1 | 2017 | 403 | 0.120 |
Why?
|
Cell Division | 2 | 2004 | 4475 | 0.120 |
Why?
|
T-Lymphocyte Subsets | 3 | 2016 | 1811 | 0.120 |
Why?
|
Lymphocyte Depletion | 1 | 2016 | 605 | 0.110 |
Why?
|
Nitriles | 1 | 2019 | 982 | 0.110 |
Why?
|
Brain Edema | 1 | 2018 | 602 | 0.110 |
Why?
|
Niacinamide | 1 | 2016 | 419 | 0.110 |
Why?
|
HLA Antigens | 1 | 2019 | 1339 | 0.110 |
Why?
|
Busulfan | 3 | 2021 | 264 | 0.110 |
Why?
|
Combined Modality Therapy | 3 | 2024 | 8529 | 0.110 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2024 | 1484 | 0.110 |
Why?
|
Receptors, Interleukin-2 | 1 | 2015 | 561 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2017 | 1617 | 0.110 |
Why?
|
Adolescent | 13 | 2024 | 88835 | 0.110 |
Why?
|
Remission Induction | 2 | 2016 | 2411 | 0.100 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 536 | 0.100 |
Why?
|
Drug Resistance | 1 | 2019 | 1591 | 0.100 |
Why?
|
Consensus | 1 | 2023 | 3202 | 0.100 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2016 | 497 | 0.100 |
Why?
|
DNA-Binding Proteins | 4 | 2021 | 9601 | 0.100 |
Why?
|
Lymphocyte Count | 3 | 2019 | 790 | 0.100 |
Why?
|
Histocompatibility Testing | 3 | 2015 | 726 | 0.100 |
Why?
|
Repressor Proteins | 2 | 2020 | 2968 | 0.100 |
Why?
|
Models, Immunological | 1 | 2014 | 517 | 0.100 |
Why?
|
Child | 8 | 2023 | 80564 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2832 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2666 | 0.090 |
Why?
|
Incidence | 4 | 2023 | 21480 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1560 | 0.090 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1009 | 0.090 |
Why?
|
Mutation | 6 | 2021 | 30198 | 0.090 |
Why?
|
Saccharomyces cerevisiae | 1 | 2022 | 2674 | 0.090 |
Why?
|
Cell Separation | 1 | 2016 | 1718 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1742 | 0.090 |
Why?
|
Cell Proliferation | 4 | 2019 | 10429 | 0.090 |
Why?
|
Lymphoma, B-Cell | 1 | 2017 | 943 | 0.090 |
Why?
|
Receptors, IgE | 2 | 2003 | 374 | 0.090 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2014 | 614 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1946 | 0.090 |
Why?
|
Prognosis | 6 | 2022 | 29922 | 0.090 |
Why?
|
Cytomegalovirus | 1 | 2015 | 751 | 0.090 |
Why?
|
Phagocytosis | 2 | 2015 | 1520 | 0.090 |
Why?
|
Stilbenes | 1 | 2011 | 154 | 0.090 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2016 | 975 | 0.090 |
Why?
|
Herpesvirus 8, Human | 2 | 2004 | 254 | 0.090 |
Why?
|
Boronic Acids | 1 | 2014 | 916 | 0.090 |
Why?
|
Hematopoiesis | 2 | 2017 | 2058 | 0.080 |
Why?
|
Neoplasms | 3 | 2024 | 22340 | 0.080 |
Why?
|
Alleles | 4 | 2024 | 6897 | 0.080 |
Why?
|
Prednisone | 1 | 2014 | 1565 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4348 | 0.080 |
Why?
|
Plasmapheresis | 1 | 2010 | 205 | 0.080 |
Why?
|
United States | 8 | 2024 | 72903 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1602 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3596 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1383 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1050 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1857 | 0.080 |
Why?
|
Glioblastoma | 1 | 2024 | 3459 | 0.080 |
Why?
|
Epitopes | 1 | 2015 | 2523 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2016 | 18973 | 0.080 |
Why?
|
Phenotype | 2 | 2018 | 16721 | 0.080 |
Why?
|
Pyrazines | 1 | 2014 | 1204 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2020 | 2067 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2822 | 0.070 |
Why?
|
Whole-Body Irradiation | 2 | 2019 | 438 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2019 | 16047 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2016 | 5696 | 0.070 |
Why?
|
Erythropoiesis | 1 | 2011 | 691 | 0.070 |
Why?
|
Erythrocytes | 1 | 2016 | 2395 | 0.070 |
Why?
|
Pyrimidines | 1 | 2019 | 3047 | 0.070 |
Why?
|
Survival Analysis | 5 | 2018 | 10070 | 0.070 |
Why?
|
Age Factors | 3 | 2024 | 18380 | 0.070 |
Why?
|
Fas Ligand Protein | 2 | 2003 | 214 | 0.060 |
Why?
|
Cell Line, Tumor | 4 | 2018 | 17075 | 0.060 |
Why?
|
Immunotherapy | 2 | 2019 | 4752 | 0.060 |
Why?
|
Lymphocytes | 2 | 2024 | 2599 | 0.060 |
Why?
|
Melanoma | 1 | 2024 | 5719 | 0.060 |
Why?
|
Neutropenia | 1 | 2010 | 893 | 0.060 |
Why?
|
Antigens, CD7 | 1 | 2024 | 30 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2535 | 0.060 |
Why?
|
Polyglutamic Acid | 2 | 1994 | 46 | 0.060 |
Why?
|
Trans-Activators | 2 | 2007 | 2850 | 0.060 |
Why?
|
Neutrophils | 1 | 2016 | 3776 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1624 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1882 | 0.050 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2003 | 128 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2020 | 59489 | 0.050 |
Why?
|
Societies | 1 | 2023 | 106 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2007 | 995 | 0.050 |
Why?
|
Antigens, CD | 2 | 2024 | 4025 | 0.050 |
Why?
|
RNA, Transfer, Lys | 1 | 2002 | 8 | 0.050 |
Why?
|
NF-kappa B | 1 | 2011 | 2485 | 0.050 |
Why?
|
Antigens, Viral | 1 | 2007 | 995 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2018 | 1866 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2022 | 99 | 0.050 |
Why?
|
Cell Transformation, Viral | 1 | 2003 | 527 | 0.050 |
Why?
|
Azacitidine | 1 | 2024 | 334 | 0.050 |
Why?
|
Immunologic Memory | 2 | 2016 | 1375 | 0.050 |
Why?
|
Serology | 1 | 2001 | 7 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2268 | 0.050 |
Why?
|
HIV Reverse Transcriptase | 1 | 2002 | 214 | 0.050 |
Why?
|
Graft Rejection | 1 | 2014 | 4499 | 0.050 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2022 | 262 | 0.050 |
Why?
|
Anemia | 1 | 2010 | 1511 | 0.040 |
Why?
|
Polydeoxyribonucleotides | 1 | 2022 | 136 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2022 | 894 | 0.040 |
Why?
|
Immunomodulation | 1 | 2024 | 547 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 141 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 124 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6499 | 0.040 |
Why?
|
Burkitt Lymphoma | 1 | 2002 | 338 | 0.040 |
Why?
|
Signal Transduction | 3 | 2019 | 23601 | 0.040 |
Why?
|
Methotrexate | 2 | 2018 | 1722 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 197 | 0.040 |
Why?
|
Viral Proteins | 1 | 2007 | 1797 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2003 | 1441 | 0.040 |
Why?
|
Cell Size | 1 | 2001 | 625 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 891 | 0.040 |
Why?
|
Biopsy | 1 | 2010 | 6763 | 0.040 |
Why?
|
Leukemia, Myeloid | 1 | 2021 | 696 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1740 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 1106 | 0.040 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2000 | 435 | 0.040 |
Why?
|
Melphalan | 1 | 2019 | 425 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 74840 | 0.040 |
Why?
|
Acute Disease | 2 | 2020 | 7232 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1745 | 0.040 |
Why?
|
Benzylamines | 1 | 2018 | 251 | 0.040 |
Why?
|
Immediate-Early Proteins | 1 | 2000 | 444 | 0.040 |
Why?
|
Cell Line | 4 | 2004 | 15543 | 0.040 |
Why?
|
Th1 Cells | 1 | 2002 | 1039 | 0.030 |
Why?
|
Coculture Techniques | 2 | 2016 | 1336 | 0.030 |
Why?
|
Simian immunodeficiency virus | 1 | 2002 | 812 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 898 | 0.030 |
Why?
|
Time Factors | 4 | 2021 | 40065 | 0.030 |
Why?
|
Leukopenia | 1 | 2017 | 213 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 4520 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 2002 | 0.030 |
Why?
|
Lymphocyte Cooperation | 1 | 2016 | 112 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13648 | 0.030 |
Why?
|
Pilot Projects | 2 | 2020 | 8733 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1599 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 647 | 0.030 |
Why?
|
STAT5 Transcription Factor | 1 | 2016 | 269 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 862 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2022 | 39193 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2003 | 3690 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4772 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1672 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1595 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9373 | 0.030 |
Why?
|
Animals | 5 | 2024 | 168764 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2015 | 18071 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2007 | 3211 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2017 | 870 | 0.030 |
Why?
|
Lymphopoiesis | 1 | 2016 | 132 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2007 | 5881 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10850 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14071 | 0.030 |
Why?
|
Graft Survival | 2 | 2017 | 3890 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 834 | 0.030 |
Why?
|
Virus Replication | 1 | 2002 | 2447 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1808 | 0.030 |
Why?
|
Platelet Count | 1 | 2017 | 782 | 0.030 |
Why?
|
Anticoagulants | 1 | 2010 | 4862 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2004 | 3222 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1831 | 0.030 |
Why?
|
Chemoembolization, Therapeutic | 1 | 1994 | 129 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3344 | 0.030 |
Why?
|
Leukemia | 1 | 2021 | 1522 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2016 | 852 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10729 | 0.030 |
Why?
|
Antibody Formation | 1 | 2017 | 1391 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2016 | 633 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5389 | 0.030 |
Why?
|
Plasma Cells | 1 | 2016 | 591 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2003 | 2747 | 0.020 |
Why?
|
RNA | 1 | 2002 | 2717 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3271 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2021 | 2844 | 0.020 |
Why?
|
Death | 1 | 2016 | 686 | 0.020 |
Why?
|
Cell Count | 1 | 2016 | 1823 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9550 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1789 | 0.020 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 2011 | 195 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3421 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13632 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1880 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21056 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2020 | 3404 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8703 | 0.020 |
Why?
|
Skin Diseases | 1 | 2019 | 1088 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2601 | 0.020 |
Why?
|
Erythroid Precursor Cells | 1 | 2011 | 211 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2194 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2019 | 2324 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3426 | 0.020 |
Why?
|
Antibodies | 1 | 2017 | 2417 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 786 | 0.020 |
Why?
|
Lung Diseases | 1 | 2019 | 1940 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4270 | 0.020 |
Why?
|
Cisplatin | 1 | 1994 | 1658 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3850 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4108 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4255 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 54802 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6274 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9338 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 41649 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2016 | 2867 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13451 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5508 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12437 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2942 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1333 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22332 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9249 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4209 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81819 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18293 | 0.010 |
Why?
|
HIV-1 | 1 | 2002 | 6944 | 0.010 |
Why?
|
Contactins | 1 | 2004 | 21 | 0.010 |
Why?
|
Survivors | 1 | 2014 | 2372 | 0.010 |
Why?
|
Genetic Variation | 1 | 2019 | 6610 | 0.010 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2004 | 122 | 0.010 |
Why?
|
Binding Sites | 2 | 2002 | 6001 | 0.010 |
Why?
|
Child, Preschool | 2 | 2021 | 42500 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2011 | 1608 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7584 | 0.010 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2002 | 152 | 0.010 |
Why?
|
HLA-DQ Antigens | 1 | 2002 | 190 | 0.010 |
Why?
|
Viral Core Proteins | 1 | 2002 | 158 | 0.010 |
Why?
|
Base Sequence | 2 | 2003 | 12403 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12056 | 0.010 |
Why?
|
Gene Products, gag | 1 | 2002 | 317 | 0.010 |
Why?
|
Models, Molecular | 1 | 2011 | 5379 | 0.010 |
Why?
|
Glycosylation | 1 | 2004 | 1100 | 0.010 |
Why?
|
Phosphonoacetic Acid | 1 | 2000 | 54 | 0.010 |
Why?
|
Contrast Media | 1 | 1994 | 5329 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2002 | 608 | 0.010 |
Why?
|
Particle Size | 2 | 1994 | 1631 | 0.010 |
Why?
|
Nucleotides | 1 | 2002 | 451 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36386 | 0.010 |
Why?
|
Pyridines | 1 | 2011 | 2888 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2825 | 0.010 |
Why?
|
Deoxyribonucleases | 1 | 2000 | 209 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2274 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2002 | 825 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 2002 | 901 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4165 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2002 | 1525 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2000 | 618 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11868 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5337 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24282 | 0.010 |
Why?
|
Iopanoic Acid | 1 | 1994 | 20 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6493 | 0.010 |
Why?
|
Capsules | 1 | 1994 | 193 | 0.010 |
Why?
|
DNA, Viral | 1 | 2000 | 2199 | 0.010 |
Why?
|
Estrone | 1 | 1994 | 234 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6113 | 0.010 |
Why?
|
Enzymes | 1 | 1994 | 254 | 0.010 |
Why?
|
Escherichia coli | 1 | 2004 | 4214 | 0.010 |
Why?
|
Microspheres | 1 | 1994 | 773 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5125 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1994 | 2266 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17594 | 0.010 |
Why?
|
Drug Carriers | 1 | 1994 | 700 | 0.010 |
Why?
|
Rabbits | 1 | 1994 | 4734 | 0.000 |
Why?
|
Receptors, Estrogen | 1 | 1994 | 2242 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2000 | 12768 | 0.000 |
Why?
|
Swine | 1 | 1994 | 5988 | 0.000 |
Why?
|
Liver | 1 | 1994 | 7562 | 0.000 |
Why?
|
Rats | 1 | 1994 | 23707 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1994 | 20659 | 0.000 |
Why?
|